Absorbable Hemostats Market Report 2026

Absorbable Hemostats Market Overview

• Absorbable Hemostats market size has reached to $3.37 billion in 2025 • Expected to grow to $4.96 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Rising Surgical Procedures Fuel Growth In Absorbable Hemostats Market • Market Trend: Technological Advancements In Absorbable Hemostats • North America was the largest region in 2025.

The key promising market opportunities in the absorbable hemostats market include: • Hospitals And Clinics (Segmentation By End-User) → Expected gain of $949.64 Million • Gelatin-Based Hemostats (Segmentation By Type) → Expected gain of $510.46 Million • Ambulatory Surgical Centers (Segmentation By End-User) → Expected gain of $494.09 Million

What Is Covered Under Absorbable Hemostats Market?

An absorbable hemostat is a medical device used to control bleeding during surgical procedures. It is designed to promote blood clotting and stabilize hemorrhaging tissues. An absorbable hemostat is made from materials that can be gradually broken down and absorbed by the body over time, eliminating the need for surgical removal. The main absorbable hemostats are thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, collagen-based hemostats, and others. Thrombin-based hemostats are products that contain thrombin, an enzyme that helps blood clot by converting fibrinogen into fibrin. It is applied for neurosurgery, orthopedic surgery, general surgery, reconstructive surgery, and others by various end-users such as hospitals and clinics, ambulatory surgical centers, and others.

What Is The Absorbable Hemostats Market Growth Forecast?

The absorbable hemostats market size is expected to see strong growth in the next few years. It will grow to $4.96 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising usage of advanced thrombin and collagen-based formulations, growing shift toward minimally invasive and reconstructive surgeries, increasing investment in bioabsorbable and hybrid hemostat innovation, expansion of ambulatory surgical center procedure volumes, rising focus on reducing surgical complications and recovery time. Major trends in the forecast period include increasing development of bioengineered absorbable hemostat materials for enhanced tissue compatibility, rising adoption of advanced collagen, gelatin, and thrombin-based hemostats in complex surgical procedures, growing preference for multifunctional hemostatic products supporting rapid clot stabilization and wound healing, expanding utilization of absorbable hemostats in minimally invasive and reconstructive surgeries, increasing clinical focus on hemostats designed to reduce post-operative complications and surgical bleeding risks.

What Is The Driver Of The Absorbable Hemostats Market?

The increasing number of surgical procedures is expected to drive the growth of the absorbable hemostats market going forward. Surgical procedures are medical operations performed to treat, diagnose, or manage conditions by physically altering tissues or organs through incisions or other techniques. The increase in surgical procedures is due to increasing demand for advanced medical treatments, an aging population, and advancements in surgical technology that enable more complex and minimally invasive operations. Absorbable hemostats are used for surgical procedures to control bleeding and promote clot formation while being gradually absorbed by the body, reducing the need for additional interventions and minimizing postoperative complications. For instance, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a UK-based professional organization, a total of 25,972 surgical procedures were performed in 2023, with women representing 93% of all cosmetic surgeries. Men made up the remaining 7% of these cases. Therefore, the increasing number of surgical procedures is driving the growth of the absorbable hemostasis market.

How Will The Drivers Impact Growth In The Global Absorbable Hemostats Market?

• Growing Prevalence of Chronic Diseases (Medium) – The growing prevalence of chronic diseases will become a key driver of growth in the absorbable hemostats market by 2030. Patients with chronic diseases often face an increased risk of bleeding during surgical procedures, making effective bleeding management crucial to minimizing complications and improving outcomes. Hemostatic agents play a vital role in ensuring efficient hemostasis for these high-risk patients, driving their widespread use in clinical settings. As a result, the growing prevalence of chronic diseases is anticipated to contributing to annual growth in the market. • Growing Aging Population (Low) – The growing aging population will emerge as a major factor driving the expansion of the absorbable hemostats market by 2030. The aging population fuels demand for absorbable hemostats as older individuals are more prone to chronic diseases, age-related conditions and surgical interventions such as cardiovascular, orthopedic and cancer-related procedures. Their reduced ability to heal and heightened risk of bleeding complications make absorbable hemostats essential for effective bleeding management and improved recovery outcomes in this demographic. As a result, the growing aging population is anticipated to contributing to annual growth in the market. • Surge in Orthopedic Surgeries (Low) – The surge in orthopedic surgeries will serve as a key growth catalyst for the absorbable hemostats market by 2030. Orthopedic surgeries are driven by factors such as the growing aging population, increasing prevalence of musculoskeletal disorders, rising incidence of sports and traumatic injuries, advancements in surgical techniques and the demand for improved quality of life and mobility. The rising number of orthopedic surgeries fuels the growth of absorbable hemostats, as they are crucial for managing bleeding, improving patient outcomes and reducing complications in procedures like joint replacements, fractures and reconstructive surgeries. As a result, the surge in orthopedic surgeries is anticipated to contributing to annual growth in the market.

How Will The Restraints Impact Growth In The Global Absorbable Hemostats Market?

• Supply Chain Disruptions (Medium) – Supply Chain Disruptions will restrict the growth of the Absorbable Hemostats market during the forecast period. The production of absorbable hemostats relies on complex supply chains for raw materials including gelatin, collagen, and specialized manufacturing equipment. Supply chain disruptions can affect product availability, increase costs, and create uncertainties for healthcare providers. Dependence on limited suppliers and geographical concentration of production capacity create vulnerability to supply disruptions, affecting market stability and growth.

Key Players In The Global Absorbable Hemostats Market

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., Omrix Biopharmaceuticals Inc.

Global Absorbable Hemostats Market Trends and Insights

Major companies in the absorbable hemostats market are focused on developing advanced products, such as absorbable hemostatic powder, to provide rapid and effective bleeding control during surgery. The absorbable hemostatic powder is a medical product used to control bleeding by promoting rapid clot formation at the site of injury, and the body naturally absorbs it after fulfilling its function. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT absorbable hemostatic powder. PERCLOT granules possess a unique molecular structure that rapidly absorbs water, forming a gelled adhesive matrix that creates a mechanical barrier to stop bleeding by promoting the accumulation of platelets, red blood cells, and coagulation proteins like thrombin and fibrinogen. This feature enhances clinicians' ability to manage a broader range of intraoperative bleeding, which is crucial in reducing the need for blood transfusions, minimizing major complications, and ultimately lowering the overall cost of care.

What Are Latest Mergers And Acquisitions In The Absorbable Hemostats Market?

In April 2024, Integra LifeSciences Holdings Corporation, a US-based science company, acquired Acclarent Inc. for an undisclosed amount. The acquisition aims to strengthen Integra LifeSciences' presence in the ENT surgical interventions market by integrating Acclarent's innovative product portfolio. This expansion is expected to provide new growth opportunities and enhance the company's market position. Acclarent Inc. is a US-based healthcare company that specializes in providing absorbable hemostats and absorbable hemostats.

What Defines the Absorbable Hemostats Market?

The absorbable hemostats market consists of sales of fibrin sealants, hemostatic powders, absorbable sponges, hemostatic plugs and absorbable mats. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Absorbable Hemostats Market Report 2026?

The absorbable hemostats market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the absorbable hemostats industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.